Compare MXCT & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MXCT | BAER |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 113.0M |
| IPO Year | 2021 | 2023 |
| Metric | MXCT | BAER |
|---|---|---|
| Price | $1.37 | $1.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $5.50 | $5.00 |
| AVG Volume (30 Days) | 881.8K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.15 |
| EPS | ★ N/A | N/A |
| Revenue | $33,026,000.00 | ★ $122,830,000.00 |
| Revenue This Year | N/A | $16.47 |
| Revenue Next Year | $18.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 24.56 |
| 52 Week Low | $0.64 | $1.12 |
| 52 Week High | $1.86 | $3.44 |
| Indicator | MXCT | BAER |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 32.51 |
| Support Level | $1.19 | $1.12 |
| Resistance Level | $1.54 | $2.03 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 62.98 | 12.86 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.